17 Capital Partners’s Xylem XYL Stock Holding History

17 Capital Partners’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,492	Closed	-$1.49M	–	157
2025 Q1	$1.49M	Buy	12,492 +35	+0.3%	+$4.34K	0.96%	29
2024 Q4	$1.45M	Sell	12,457 -275	-2%	-$34.8K	0.92%	30
2024 Q3	$1.72M	Hold	12,732	–	–	1.12%	17
2024 Q2	$1.73M	Hold	12,732	–	–	1.23%	16
2024 Q1	$1.65M	Hold	12,732	–	–	1.22%	19
2023 Q4	$1.46M	Buy	+12,732	New	+$1.27M	1.34%	21
2022 Q3	$1.06M	Sell	12,133 -40	-0.3%	-$3.64K	1.45%	30
2022 Q2	$952K	Hold	12,173	–	–	1.2%	38
2022 Q1	$1.04M	Buy	12,173 +35	+0.3%	+$3.35K	1.08%	40
2021 Q4	$1.46M	Sell	12,138 -659	-5%	-$81.8K	1.33%	23
2021 Q3	$1.58M	Buy	12,797 +65	+0.5%	+$8.37K	1.49%	14
2021 Q2	$1.53M	Buy	+12,732	New	+$1.45M	1.42%	19

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

17 Capital Partners's XYL Position: Q2 2025 in Review

17 Capital Partners sold out of Xylem (XYL) in Q2 2025, closing a stake of 12,492 shares — an estimated $1.49M sold.

17 Capital Partners first reported a position in XYL in Q2 2021 and held it in 12 quarters. The position peaked at $1.73M in Q2 2024. 1,063 funds tracked by Wall St. Rank hold XYL as of Q2 2025.

17 Capital Partners reported no remaining Xylem position as of Q2 2025 after selling out during the quarter.
17 Capital Partners sold 12,492 Xylem shares in Q2 2025, an estimated $1.49M.
17 Capital Partners first reported a position in Xylem in Q2 2021 and held it in 12 quarters.
17 Capital Partners's Xylem position peaked at $1.73M in Q2 2024.
1,063 funds tracked by Wall St. Rank held Xylem as of Q2 2025.

Based on 17 Capital Partners's 13F filing for Q2 2025, filed 12 Aug 2025.